abstract |
The present invention relates to a fully human monoclonal antibody recognizing an IL-17F, IL-17F homodimer, IL-17A, IL-17A homodimer, and / or a heterodimeric IL-17A / IL- Lt; / RTI > The present invention further provides a method of using the monoclonal antibody as a therapeutic agent, a diagnostic agent, and a prophylactic agent. |